Risperidon- und/oder Paliperidonimplantatformulierung

Patent europeic · EP2529756 · En vigur

Inscripziun en il register

Numer da publicaziun
EP2529756
Numer da la dumonda
EP12170362
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
31-05-2012
Publitgà
05-12-2012
Concedì
19-05-2021
La protecziun finescha il pli tard
30-05-2032
Proxima taxa annuala scadenta
31-05-2026
Classas IPC
A61K 47/34 (2017.01)
A61K 31/519 (2006.01)
Prioritad
WO PCT/EP2011/059000 31.05.2011
WO PCT/EP2011/059001 31.05.2011
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 01-06-2025

    Midada

    Published in Swissreg on 01.06.2025

  2. 02-06-2024

    Midada

    Published in Swissreg on 02.06.2024

  3. 02-06-2023

    Midada

    Published in Swissreg on 02.06.2023

  4. 30-03-2022

    Midada

    Published in Swissreg on 30.03.2022

  5. 19-05-2021

    Concedì

    Published in Swissreg on 19.05.2021

Partidas

Possessur

LABORATORIOS FARMACEUTICOS ROVI, S.A.

c/Julián Camarillo, 35, 28037 Madrid, ES

Inventur

Franco Rodriguez, Guillermo

28037 Madrid, ES

Gutierro Aduriz, Ibon

28037 Madrid, ES

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.